Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Georgian medical news. 2020-Mar

INFLUENCE OF PHYTOCOMPOSITIONS ON DYNAMICS OF CHANGES IN BASAL GLYCEMIA AND GLYCEMIA IN ORAL GLUCOSE TOLERANCE TEST IN RATS WITH STREPTOZOTOCIN-NICOTINAMIDE-INDUCED DIABETES MELLITUS TYPE 2.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Link salvestatakse lõikelauale
Kh Kurylo
L Budniak
A Volska
B Zablotskyy
I Klishch

Märksõnad

Abstraktne

Diabetes mellitus is one of the global medical, social and economic problems of today.Therefore, it is important to develop a new mechanism of action with fewer side effects that can reduce glycemia and insulin resistance. The aim of the study was to determine the effect of phytocompositions on the basis of Galega officinalis L. and Galevit in the conditions of therapeutic and prophylactic use in experimental type 2 diabetes mellitus contribute to the recovery of carbohydrate metabolism.on the dynamics of changes in basal glycemia and glycemia after oral glucose tolerance test in animals under conditions of experimental streptozotocin diabetes. The composition of the maturing phytocomposition and its lipocomposite form includes dry extract Galega officinalis L. - 50.0 mg, dry extract of Vaccinium myrtillus L. leaf - 50.0 mg, taurine - 1.4 mg. Type 2 diabetes mellitus was modeled on the method of Islam S., Choi H. 50 nonlinear white rats-males body weighing 180-220 g were used for the experimental studies.All animals were randomized into 5 groups of 10 rats: 1 - control group; 2 - animals with with T2DM; 3 - animals with diabetes mellitus, which received reference drugs (Arfa combi); 4 - STZ+N and substances received phytocomposition; 5 - STZ+N and Galevit. The investigated phytocompositions were administered intragastrically once a day for 28 days, starting 24 h after induction of type 2 diabetes mellitus. Phytocompositionson the basis of Galega officinalis L. and Galevit in the conditions of therapeutic and prophylactic use in experimental type 2 diabetes mellitus contribute to the recovery of carbohydrate metabolism. At the effectiveness of correction of metabolic changes, in experimental diabetes mellitus, phytocomposition based on Galega officinalis L. is not inferior, and liposomal form of dry extract Galevit is dominated by the reference phyto-agent Arfa combi. The spectrum of metabolic activity and the effectiveness of the therapeutic and prophylactic action of the application of the liposomal form of this phytocomposition under the conditional name Galevit is more justified on the basis of pathological changes, and the develo-pment of a new antidiabetic herbal remedy is more expedient.

Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge